Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.
Company Information
About this company
Key people
Stuart Gander
Chief Executive Officer
Christer Samuelsson
Chief Financial Officer and Investor Relations
Henrik Jacobson
Chief Operating Officer, Production Manager
Franco Pellegrini
Vice President - Sales, EMEA
Jim Kathrein
Vice President - US Commercial Operations
Anders Ljunggren
Managing Director, Manager - Project Management Office
Victoria Lerneryd
Manager - QA/RA
Jonas Melin
Director - Product Development
Ylva Molin
Manager - Assay Development
Karl Skoeld
Director Contract Development
Johan Bygge
Independent Chairman of the Board
Mario Gualano
Deputy Independent Chairperson of the Board
Erika Kjellberg Eriksson
Director
Sebastian Backlund
Independent Director
Karin Fischer
Independent Director
Click to see more
Key facts
- Shares in issue19.31m
- EPICQLINEA
- ISINSE0025420714
- LocationSweden
- SectorTechnology
- IndustryScientific & Technical Instr.
- Market capSEK 570.65m
- Employees83
- ExchangeStockholm Stock Exchange
- IndexSX All Share PI Market Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.